Jinwon Life Sciences ranked among the top searched stocks for 14 days in the past month.


As of 1:30 PM on the 8th, Jinwon Life Sciences is trading at 26,500 KRW, down 3.99% from the previous day. This represents a 5.58% increase compared to November 25. Jinwon Life Sciences is known as a company specializing in the development of gene therapies and gene vaccines.

Today, foreigners are tentatively recorded as net sellers of 21,626 shares. Over the past five days, individual investors have been net buyers of 52,876 shares, while foreigners and institutions have been net sellers of 8,065 shares and 26,566 shares, respectively.


On December 7, Jinwon Life Sciences was a market topic with the news of domestic clinical approval for the COVID-19 vaccine, described as a 'bullish trend.'





[Table] Foreigners and Institutions Net Trading Volume (Unit: shares)

※Source: AI Investment Assistant AI Rassiro


※ This article was generated in real-time by an automatic article generation algorithm jointly developed by Asia Economy and the financial AI specialist company Thinkpool.


This content was produced with the assistance of AI translation services.

© The Asia Business Daily(www.asiae.co.kr). All rights reserved.

Today’s Briefing